D

DNA Group TR Ltd
TASE:DNA

Watchlist Manager
DNA Group TR Ltd
TASE:DNA
Watchlist
Price: 118.8 ILS 1.63% Market Closed
Market Cap: ₪995.7m

Operating Margin

-424.2%
Current
Improving
by 204.7%
vs 3-y average of -628.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-424.2%
=
Operating Income
₪-1.3m
/
Revenue
₪306k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-424.2%
=
Operating Income
₪-1.3m
/
Revenue
₪306k

Peer Comparison

Country Company Market Cap Operating
Margin
IL
DNA Group TR Ltd
TASE:DNA
995.7m ILS
Loading...
JP
Keyence Corp
TSE:6861
14.3T JPY
Loading...
CN
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
294.9B CNY
Loading...
US
Keysight Technologies Inc
NYSE:KEYS
38.3B USD
Loading...
SE
Hexagon AB
STO:HEXA B
270.7B SEK
Loading...
US
Teledyne Technologies Inc
NYSE:TDY
29.1B USD
Loading...
CN
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
193.2B CNY
Loading...
UK
Halma PLC
LSE:HLMA
13.5B GBP
Loading...
US
Trimble Inc
NASDAQ:TRMB
16.7B USD
Loading...
TW
Chroma ATE Inc
TWSE:2360
438.4B TWD
Loading...
US
Zebra Technologies Corp
NASDAQ:ZBRA
12B USD
Loading...

Market Distribution

Lower than 92% of companies in Israel
Percentile
8th
Based on 734 companies
8th percentile
-424.2%
Low
-84 760% — -5.8%
Typical Range
-5.8% — 10.9%
High
10.9% — 23 869.1%
Distribution Statistics
Israel
Min -84 760%
30th Percentile -5.8%
Median 4%
70th Percentile 10.9%
Max 23 869.1%

DNA Group TR Ltd
Glance View

Market Cap
995.7m ILS
Industry
Electrical Equipment

DNA Group (T.R.)Ltd. engages in biotechnology. The firm's areas of activity include: the evaluation of bone density by measuring the velocity of the propagation of sound waves across the bone, using Bimmed, as well as the development of oral delivery of drugs, through its subsidiary, Entera Bio Ltd. Entera Bio Ltd focuses on the development of oral delivery of large molecules to address unmet medical needs. Entera Bio Ltd holds a patent, combining the following technologies: a synthetic molecule absorption enhancer, facilitating the absorption of large molecules and a proprietary formulation to prevent molecule degradation. Entera Bio Ltd’s proprietary oral delivery platform can be applied to a range of large molecules and biologicals. Entera Bio Ltd’s drugs are designated for the following medical conditions: Hypoparathyroidism and Osteoporosis.

DNA Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-424.2%
=
Operating Income
₪-1.3m
/
Revenue
₪306k
What is DNA Group TR Ltd's current Operating Margin?

The current Operating Margin for DNA Group TR Ltd is -424.2%, which is above its 3-year median of -628.9%.

How has Operating Margin changed over time?

Over the last 3 years, DNA Group TR Ltd’s Operating Margin has increased from -1 017.7% to -424.2%. During this period, it reached a low of -1 017.7% on Dec 31, 2022 and a high of -424.2% on Jul 30, 2025.

Back to Top